These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7851937)

  • 21. Cloning, expression, post-translational modifications and inhibition studies on the latest mammalian carbonic anhydrase isoform, CA XV.
    Hilvo M; Salzano AM; Innocenti A; Kulomaa MS; Scozzafava A; Scaloni A; Parkkila S; Supuran CT
    J Med Chem; 2009 Feb; 52(3):646-54. PubMed ID: 19193158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Introduction to the carbonic anhydrases.
    Chegwidden WR; Carter ND
    EXS; 2000; (90):14-28. PubMed ID: 11268513
    [No Abstract]   [Full Text] [Related]  

  • 23. Carbonic anhydrase inhibitors. Inhibition of the Rv1284 and Rv3273 beta-carbonic anhydrases from Mycobacterium tuberculosis with diazenylbenzenesulfonamides.
    Maresca A; Carta F; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2009 Sep; 19(17):4929-32. PubMed ID: 19651511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical localization of carbonic anhydrase isoenzymes in the human pancreas.
    Kumpulainen T; Jalovaara P
    Gastroenterology; 1981 Apr; 80(4):796-9. PubMed ID: 6781974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis.
    Nishimori I; Minakuchi T; Vullo D; Scozzafava A; Innocenti A; Supuran CT
    J Med Chem; 2009 May; 52(9):3116-20. PubMed ID: 19338333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Biological research progress of carbonic anhydrase].
    Zhang P; Li XJ
    Sheng Li Ke Xue Jin Zhan; 1997 Oct; 28(4):359-61. PubMed ID: 11038693
    [No Abstract]   [Full Text] [Related]  

  • 27. S-glycosyl primary sulfonamides--a new structural class for selective inhibition of cancer-associated carbonic anhydrases.
    Lopez M; Paul B; Hofmann A; Morizzi J; Wu QK; Charman SA; Innocenti A; Vullo D; Supuran CT; Poulsen SA
    J Med Chem; 2009 Oct; 52(20):6421-32. PubMed ID: 19827837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal structure of human carbonic anhydrase XIII and its complex with the inhibitor acetazolamide.
    Di Fiore A; Monti SM; Hilvo M; Parkkila S; Romano V; Scaloni A; Pedone C; Scozzafava A; Supuran CT; De Simone G
    Proteins; 2009 Jan; 74(1):164-75. PubMed ID: 18618712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of carbonic anhydrase isozymes with benzene sulfonamides incorporating thio, sulfinyl and sulfonyl glycoside moieties.
    Singer M; Lopez M; Bornaghi LF; Innocenti A; Vullo D; Supuran CT; Poulsen SA
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2273-6. PubMed ID: 19286378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Which carbonic anhydrases are targeted by the antiepileptic sulfonamides and sulfamates?
    De Simone G; Scozzafava A; Supuran CT
    Chem Biol Drug Des; 2009 Sep; 74(3):317-21. PubMed ID: 19703035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploration of the binding mode of indanesulfonamides as selective inhibitors of human carbonic anhydrase type VII by targeting Lys 91.
    Thiry A; Masereel B; Dogné JM; Supuran CT; Wouters J; Michaux C
    ChemMedChem; 2007 Sep; 2(9):1273-80. PubMed ID: 17607683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbonic anhydrase inhibitors. Inhibition of transmembrane isozymes XII (cancer-associated) and XIV with anions.
    Innocenti A; Vullo D; Pastorek J; Scozzafava A; Pastorekova S; Nishimori I; Supuran CT
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1532-7. PubMed ID: 17257840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbonic anhydrase inhibitor coated gold nanoparticles selectively inhibit the tumor-associated isoform IX over the cytosolic isozymes I and II.
    Stiti M; Cecchi A; Rami M; Abdaoui M; Barragan-Montero V; Scozzafava A; Guari Y; Winum JY; Supuran CT
    J Am Chem Soc; 2008 Dec; 130(48):16130-1. PubMed ID: 18989963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbonic anhydrases as targets for medicinal chemistry.
    Supuran CT; Scozzafava A
    Bioorg Med Chem; 2007 Jul; 15(13):4336-50. PubMed ID: 17475500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. QSAR studies for the inhibition of the transmembrane isozymes XII and XIV of human carbonic anhydrase with a series of sulfonamides.
    Tarko L; Supuran CT
    Bioorg Med Chem; 2007 Sep; 15(17):5666-71. PubMed ID: 17574422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proceedings of the 6th International Conference on Carbonic Anhydrases. June, 2003. Bratislava, Slovak Republic.
    J Enzyme Inhib Med Chem; 2004 Jun; 19(3):199-291. PubMed ID: 15560002
    [No Abstract]   [Full Text] [Related]  

  • 37. Activation of carbonic anhydrase isozymes.
    Supuran CT; Scozzafava A
    EXS; 2000; (90):197-219. PubMed ID: 11268517
    [No Abstract]   [Full Text] [Related]  

  • 38. Structure and metal exchange in the cadmium carbonic anhydrase of marine diatoms.
    Xu Y; Feng L; Jeffrey PD; Shi Y; Morel FM
    Nature; 2008 Mar; 452(7183):56-61. PubMed ID: 18322527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-protein interactions. Refined structures of three sulfonamide drug complexes of human carbonic anhydrase I enzyme.
    Chakravarty S; Kannan KK
    J Mol Biol; 1994 Oct; 243(2):298-309. PubMed ID: 7932756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional interaction of carbonic anhydrase and chloride/bicarbonate exchange in human platelets.
    Gende OA
    Platelets; 2005 Nov; 16(7):392-7. PubMed ID: 16236600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.